Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Abstract A5: Functional role of SOX2 in hypoxia-mediated metastasis-associated functions in prostate cancer

Yao Dai, Kyung-Mi Bae, Johannes Vieweg, Dietmar W. Siemann

Cancer Res (2013) 73 (3_Supplement): A5.

https://doi.org/10.1158/1538-7445.TIM2013-A5

Published: 01 May 2014

View articletitled, Abstract A5: Functional role of SOX2 in hypoxia-mediated metastasis-associated functions in prostate cancer

Journal Articles

Tumor-Associated Macrophages Mediate Immunosuppression in the Renal Cancer Microenvironment by Activating the 15-Lipoxygenase-2 Pathway

Irina Daurkin, Evgeniy Eruslanov, Taryn Stoffs, George Q. Perrin, Chester Algood, Scott M. Gilbert, Charles J. Rosser, Li-Ming Su, Johannes Vieweg, Sergei Kusmartsev

Cancer Res (2011) 71 (20): 6400–6409.

https://doi.org/10.1158/0008-5472.CAN-11-1261

Published: 12 October 2011

View articletitled, Tumor-Associated Macrophages Mediate Immunosuppression in the Renal Cancer Microenvironment by Activating the 15-Lipoxygenase-2 Pathway

Includes: Supplementary data

Journal Articles

Abstract 485: Hypoxia increases the expression of stem-cell markers and promotes cell invasion in prostate cancer cells

Kyungmi Bae, Yao Dai, Johannes Vieweg, Dietmar Siemann

Cancer Res (2011) 71 (8_Supplement): 485.

https://doi.org/10.1158/1538-7445.AM2011-485

Published: 15 April 2011

View articletitled, Abstract 485: Hypoxia increases the expression of stem-cell markers and promotes cell invasion in prostate cancer cells

Journal Articles

Abstract 5328: Expansion of CD11b⁺CD33^lowCD15^high immunosuppressive myeloid cell population in patients with bladder carcinoma

Sergei A. Kusmartsev, Evgeniy Eruslanov, Molly McCullers, Charles Rosser, Irina Daurkin, Charles Vincent, Daniel Willis, Johannes Vieweg

Cancer Res (2010) 70 (8_Supplement): 5328.

https://doi.org/10.1158/1538-7445.AM10-5328

Published: 15 April 2010

View articletitled, Abstract 5328: Expansion of CD11b+CD33lowCD15high immunosuppressive myeloid cell population in patients with bladder carcinoma

Journal Articles

Abstract #4141: Impaired PGE₂catabolism in tumor-infiltrated CD11b myeloid cells

Evgeniy Eruslanov, Johannes Vieweg, Sergei Kusmartsev

Cancer Res (2009) 69 (9_Supplement): 4141.

Published: 01 May 2009

View articletitled, Abstract #4141: Impaired PGE2 catabolism in tumor-infiltrated CD11b myeloid cells

Journal Articles

Oxidative stress regulates expression of VEGFR1+ in myeloid cells: Link to angiogenesis and tumor-induced immune suppression in renal cell carcinoma

Evgeniy Eruslanov, Yoshihisa Sakai, Charles Rosser, Dietmar Siemann, Johannes Vieweg, Sergei Kusmartsev

Cancer Res (2008) 68 (9_Supplement): 283.

Published: 01 May 2008

View articletitled, Oxidative stress regulates expression of VEGFR1+ in myeloid cells: Link to angiogenesis and tumor-induced immune suppression in renal cell carcinoma

Journal Articles

Expression of pluripotent stem cell genes by prostate tumor-initiating cells

Johannes Vieweg, Siqing Wang, Kyung-Mi Bae, Karrune Woan, Charles J. Rosser Rosser, Philipp Dahm, Vicky Kelley, Marda Jorgensen, Dennis Steindler, Zhen Su

Cancer Res (2008) 68 (9_Supplement): 2037.

Published: 01 May 2008

View articletitled, Expression of pluripotent stem cell genes by prostate tumor-initiating cells

Journal Articles

Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions

Zhen Su, Fusheng Wei, Carole Frye, Kyun-mi Bae, Siqing Wang, Vicky Kelley, Johannes Vieweg

Cancer Res (2008) 68 (9_Supplement): 4996.

Published: 01 May 2008

View articletitled, Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions

Journal Articles

Correction of tumor-induced immune dysfunction with 15-PGDH: Implications for cancer immunotherapy

Evgeniy Eruslanov, Sergei Kaliberov, Johannes Vieweg, Sergei Kusmartsev

Cancer Res (2008) 68 (9_Supplement): 3799.

Published: 01 May 2008

View articletitled, Correction of tumor-induced immune dysfunction with 15-PGDH: Implications for cancer immunotherapy

Journal Articles

VEGFR1+CD11b+ myeloid cells in cancer patients with metastatic renal cell carcinoma: link to tumor-induced immune suppression and angiogenesis

Sergei Kusmartsev, Hubert Kubler, Eugeniy Eruslanov, Zhen Su, Philipp Dahm, Johannes Vieweg

Cancer Res (2007) 67 (9_Supplement): 2552.

Published: 01 May 2007

View articletitled, VEGFR1+CD11b+ myeloid cells in cancer patients with metastatic renal cell carcinoma: link to tumor-induced immune suppression and angiogenesis

Journal Articles

Stimulation of potent antigen-specific T-cell responses using semiallogenic dendritic cells derived from human embryonic stem cells

Zhen Su, Fusheng Wei, Siqing Wang, Vicky Kelley, Philipp Dahm, Johannes Vieweg

Cancer Res (2007) 67 (9_Supplement): 1846.

Published: 01 May 2007

View articletitled, Stimulation of potent antigen-specific T-cell responses using semiallogenic dendritic cells derived from human embryonic stem cells

Journal Articles

TIE-2 is a promising anti-angiogenic target for immunotherapy of renal cell cancer

Jens Dannull, Hubert R. Kuebler, Timothy T. Tseng, Philipp Dahm, Aijing Zhang, Johannes Vieweg

Cancer Res (2006) 66 (8_Supplement): 278.

Published: 15 April 2006

View articletitled, TIE-2 is a promising anti-angiogenic target for immunotherapy of renal cell cancer

Journal Articles

Immature myeloid cell (ImC)- mediated immunosuppression in advanced renal cell cancer (RCC)

Jens Dannull, Hubert R. Kuebler, Timothy T. Tseng, Aijing Zhang, Zhen Su, Philipp Dahm, Johannes Vieweg

Cancer Res (2006) 66 (8_Supplement): 909.

Published: 15 April 2006

View articletitled, Immature myeloid cell (ImC)- mediated immunosuppression in advanced renal cell cancer (RCC)

Journal Articles

In situ Activation of Dendritic Cells (DC) with Imiquimod for Cancer Immunotherapy

Hubert R. Kuebler, Philipp Dahm, Timothy T. Tseng, Aijing Zhang, Doris Coleman, Johannes Vieweg, Jens Dannull

Cancer Res (2006) 66 (8_Supplement): 941.

Published: 15 April 2006

View articletitled, In situ Activation of Dendritic Cells (DC) with Imiquimod for Cancer Immunotherapy

Journal Articles

Reversal of immature myeloid cell-mediated immunosuppression

Curtis Bradney, Jens Dannull, Zhen Su, Aijing Zhang, Johannes Vieweg

Cancer Res (2005) 65 (9_Supplement): 569.

Published: 01 May 2005

View articletitled, Reversal of immature myeloid cell-mediated immunosuppression

Journal Articles

Delivery of mRNA into human dendritic cells using novel transfer peptides leads to prolonged antigen expression and potent immune responses in vivo

Zhen Su, Quinton Cancel, Philip Dahm, Johannes Vieweg, Jens Dannull

Cancer Res (2005) 65 (9_Supplement): 996.

Published: 01 May 2005

View articletitled, Delivery of mRNA into human dendritic cells using novel transfer peptides leads to prolonged antigen expression and potent immune responses in vivo

Journal Articles

Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results From A Phase I clinical trial

Zhen Su, Benjamin K. Yang, Jens Dannull, Philipp Dahm, Johannes Vieweg

Cancer Res (2004) 64 (7_Supplement): 325.

Published: 01 April 2004

View articletitled, Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results From A Phase I clinical trial

Journal Articles

Enhancement of antitumor immunity following depletion of CD4⁺CD25⁺ regulatory T cells.

Jens Dannull, Benjamin K. Yang, Zhen Su, Johannes Vieweg

Cancer Res (2004) 64 (7_Supplement): 503.

Published: 01 April 2004

View articletitled, Enhancement of antitumor immunity following depletion of CD4+CD25+ regulatory T cells.

Journal Articles

Enhanced antigen presenting function of antigen-loaded dendritic cells following cotransfection with OX40 ligand mRNA.

Jens Dannull, Smita Nair, Zhen Su, Eli Gilboa, Johannes Vieweg

Cancer Res (2004) 64 (7_Supplement): 495.

Published: 01 April 2004

View articletitled, Enhanced antigen presenting function of antigen-loaded dendritic cells following cotransfection with OX40 ligand mRNA.

Journal Articles

Immunological and Clinical Responses in Metastatic Renal Cancer Patients Vaccinated with Tumor RNA-transfected Dendritic Cells

Zhen Su, Jens Dannull, Axel Heiser, Donna Yancey, Scott Pruitt, John Madden, Doris Coleman, Donna Niedzwiecki, Eli Gilboa, Johannes Vieweg

Cancer Res (2003) 63 (9): 2127–2133.

Published: 01 May 2003

View articletitled, Immunological and Clinical Responses in Metastatic Renal Cancer Patients Vaccinated with Tumor RNA-transfected Dendritic Cells

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract A5: Functional role of SOX2 in hypoxia-mediated metastasis-associated functions in prostate cancer

Tumor-Associated Macrophages Mediate Immunosuppression in the Renal Cancer Microenvironment by Activating the 15-Lipoxygenase-2 Pathway

Abstract 485: Hypoxia increases the expression of stem-cell markers and promotes cell invasion in prostate cancer cells

Abstract 5328: Expansion of CD11b⁺CD33^lowCD15^high immunosuppressive myeloid cell population in patients with bladder carcinoma

Abstract #4141: Impaired PGE₂catabolism in tumor-infiltrated CD11b myeloid cells

Oxidative stress regulates expression of VEGFR1+ in myeloid cells: Link to angiogenesis and tumor-induced immune suppression in renal cell carcinoma

Expression of pluripotent stem cell genes by prostate tumor-initiating cells

Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions

Correction of tumor-induced immune dysfunction with 15-PGDH: Implications for cancer immunotherapy

VEGFR1+CD11b+ myeloid cells in cancer patients with metastatic renal cell carcinoma: link to tumor-induced immune suppression and angiogenesis

Stimulation of potent antigen-specific T-cell responses using semiallogenic dendritic cells derived from human embryonic stem cells

TIE-2 is a promising anti-angiogenic target for immunotherapy of renal cell cancer

Immature myeloid cell (ImC)- mediated immunosuppression in advanced renal cell cancer (RCC)

In situ Activation of Dendritic Cells (DC) with Imiquimod for Cancer Immunotherapy

Reversal of immature myeloid cell-mediated immunosuppression

Delivery of mRNA into human dendritic cells using novel transfer peptides leads to prolonged antigen expression and potent immune responses in vivo

Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results From A Phase I clinical trial

Enhancement of antitumor immunity following depletion of CD4⁺CD25⁺ regulatory T cells.

Enhanced antigen presenting function of antigen-loaded dendritic cells following cotransfection with OX40 ligand mRNA.

Immunological and Clinical Responses in Metastatic Renal Cancer Patients Vaccinated with Tumor RNA-transfected Dendritic Cells

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only